[go: up one dir, main page]

AU1393701A - Transdermal therapeutic system containing highly volatile active ingredients - Google Patents

Transdermal therapeutic system containing highly volatile active ingredients

Info

Publication number
AU1393701A
AU1393701A AU13937/01A AU1393701A AU1393701A AU 1393701 A AU1393701 A AU 1393701A AU 13937/01 A AU13937/01 A AU 13937/01A AU 1393701 A AU1393701 A AU 1393701A AU 1393701 A AU1393701 A AU 1393701A
Authority
AU
Australia
Prior art keywords
active ingredients
highly volatile
therapeutic system
containing highly
system containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13937/01A
Inventor
Ralf Kibele
Karin Klokkers
Hans-Jurgen Schluter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Hexal AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal AG filed Critical Hexal AG
Publication of AU1393701A publication Critical patent/AU1393701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a pharmaceutical, therapeutic system in the form of a plaster, containing highly volatile active ingredients as active components in a membrane system. A covering layer is embodied as a reversible composite produced by sealing an approximately active ingredient impermeable polyester against an active ingredient polymer membrane. The approximately active ingredient impermeable polyester film can be removed before use.
AU13937/01A 1999-11-27 2000-11-11 Transdermal therapeutic system containing highly volatile active ingredients Abandoned AU1393701A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19957234 1999-11-27
DE19957234A DE19957234A1 (en) 1999-11-27 1999-11-27 Pharmaceutical plaster containing essential oils
PCT/EP2000/011169 WO2001039752A2 (en) 1999-11-27 2000-11-11 Transdermal therapeutic system containing highly volatile active ingredients

Publications (1)

Publication Number Publication Date
AU1393701A true AU1393701A (en) 2001-06-12

Family

ID=7930621

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13937/01A Abandoned AU1393701A (en) 1999-11-27 2000-11-11 Transdermal therapeutic system containing highly volatile active ingredients

Country Status (5)

Country Link
EP (1) EP1231906B1 (en)
AT (1) ATE354357T1 (en)
AU (1) AU1393701A (en)
DE (2) DE19957234A1 (en)
WO (1) WO2001039752A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10063378A1 (en) * 2000-12-19 2002-06-20 Labtec Gmbh Condenser sticker for natural respiratory secretions
DE10114382A1 (en) * 2001-03-23 2002-09-26 Beiersdorf Ag Moisture-absorbing material used for plasters, medical fixings, wound coverings and bandages comprises adhesive matrix of silicon, gel former and optionally silicone resin
DE10121471A1 (en) * 2001-05-02 2002-11-07 Beiersdorf Ag Plaster for controlled release of active agent to skin or wounds, comprising adsorbent, pressure-sensitive adhesive matrix surface-doped with active agent, e.g. dexpanthenol
DE10220114A1 (en) * 2002-05-06 2003-11-20 Beiersdorf Ag Drug delivery system used for controlled release of essential oils comprises matrix plaster based on self adhesive, gas permeable polyurethane
DE10239101B4 (en) * 2002-08-27 2005-06-16 Scs Skin Care Systems Gmbh Patches for the administration of deodorants
DE10246377B4 (en) * 2002-10-04 2007-01-11 Beiersdorf Ag Process for the production of plaster systems with doped carrier materials as a reservoir
DE10304988A1 (en) * 2003-02-07 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system with improved skin adhesion
DE10341933A1 (en) * 2003-09-11 2005-04-14 Lts Lohmann Therapie-Systeme Ag Medicated skin patches containing essential oils for the treatment of colds and methods of making the same
DE102005033543A1 (en) * 2005-07-14 2007-01-18 Grünenthal GmbH A fragrance-containing transdermal therapeutic system
EP2083794A2 (en) * 2006-10-17 2009-08-05 LABTEC GESELLSCHAFT FüR TECHNOLOGISCHE FORSCHUNG UND ENTWICKLUNG MBH Adhesive label with bittering agent and fluidifying agents for natural airway secretions
DE102007023021A1 (en) * 2007-03-26 2008-10-02 Angelika-Regine Dr. med. Dietz Therapeutic patch for trigger and acupuncture points as well as for meridian therapy
DE102008059054A1 (en) * 2008-11-26 2010-05-27 Otto Bock Pur Life Science Gmbh Polyurethane patch for the transdermal application of active substances and process for its preparation
KR20150127269A (en) * 2013-03-14 2015-11-16 애버리 데니슨 코포레이션 Stabilization of essential oils within a hydrocolloid adhesive
DE102013008726A1 (en) 2013-05-23 2014-11-27 Amw Gmbh Plaster with removal aid
EP2878313A1 (en) * 2013-11-29 2015-06-03 LTS LOHMANN Therapie-Systeme AG Adhesive dressing containing essential oils and process for producing the same
CN116265023B (en) * 2021-12-16 2024-10-18 北京远大九和药业有限公司 Pharmaceutical composition for preventing and/or treating ear infection, and preparation method and application thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3216609A1 (en) * 1982-05-04 1983-11-10 Dietic Dr. Widmann Pharma + Diät GmbH, 6930 Eberbach Plaster inhalant
DE3629565A1 (en) * 1986-08-30 1988-03-03 Arno W Latzke Means for the application of transdermally absorbable active ingredients
HU203285B (en) * 1988-02-01 1991-07-29 Egyt Gyogyszervegyeszeti Gyar Method for producing transdermal preparation containing vegetable extract
DE3911617A1 (en) * 1988-10-12 1990-04-19 Klaus Brueckner Application form for pharmaceuticals esp. for treating pain or wounds - comprises sealed packed carrier layer contg. pharmaceutical which is esp. ethereal oil
US5455043A (en) * 1990-06-13 1995-10-03 Fischel-Ghodsian; Fariba Device for controlled release of vaporous medications through nasal route
DE4433191A1 (en) * 1994-09-17 1996-03-21 Lohmann Therapie Syst Lts Self-adhesive plaster for delivering active substance to the environment of a wearer
DE29511982U1 (en) * 1995-07-26 1996-02-22 Hexal Pharma GmbH, 83607 Holzkirchen band Aid
GB9720479D0 (en) * 1996-10-23 1997-11-26 Le Gall Madeleine Dressing
DE29620182U1 (en) * 1996-11-20 1997-04-10 Bb Med Product Gmbh Human therapeutic product for the treatment and / or prevention of diseases caused by vapors of essential oils
DE19712359A1 (en) * 1997-03-25 1998-10-01 Labtec Gmbh System for long-term administration of substance volatile at body temperature without irritating skin

Also Published As

Publication number Publication date
EP1231906B1 (en) 2007-02-21
DE19957234A1 (en) 2001-06-28
DE50014096D1 (en) 2007-04-05
WO2001039752A3 (en) 2001-12-06
WO2001039752A2 (en) 2001-06-07
EP1231906A2 (en) 2002-08-21
ATE354357T1 (en) 2007-03-15

Similar Documents

Publication Publication Date Title
AU1393701A (en) Transdermal therapeutic system containing highly volatile active ingredients
AU679032B2 (en) Transdermal therapeutic system with galanthamine as active ingredient
AU3912089A (en) Multilayer plaster
WO2002003969A3 (en) Transdermal therapeutic system for highly dispersed silicon dioxide
TW570815B (en) Transdermal therapeutic system (TTS) containing the active substance fentanyl
ES2152979T3 (en) TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ESTRADIOL.
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
WO2001026637A3 (en) Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid
MXPA02009103A (en) Transdermal therapeutic system for the delivery of lerisetron.
NO20031211L (en) Plastics comprising diclofenac
WO2005079750A3 (en) Films for use as dosage forms
CA2331414A1 (en) Transdermal therapeutic system for the administration of candesartan
AU4061101A (en) Packaging for a plaster containing active ingredients
AU695970B2 (en) Estradiol-TTS having water-binding additives
AU684256B2 (en) Transdermal therapeutic system for administering physostigmin through the skin, and a method of producing the system
JPS577412A (en) Plaster
JPH01100115A (en) Spreading plaster

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase